Anti-TIF1γ-positive dermatomyositis is encountered in several tumor types, including lung, breast, ovarian, colorectal, esophagogastric, squamous, and bladder cancer [7-9]. This evidence concerns the gene TRIM33 and urinary bladder cancer.